Science Forgeries, Plagiarism and Mischief

HRT Therapy Evidence Ghostwritten: The New York Times reports on a joint effort by the Times, "PloS Medicine, and the Washington DC law firm Public Justice, to compel the Federal court to release documents showing that medical research papers bylined by respected researchers were actually written by a firm hired by the pharmaceutical giant Wyeth. The "ghostwritten" papers promoted the benefits of using the Wyeth estrogen product Prempro to prevent wrinkled skin, dementia and other effects of menopause. However the papers didn't give adequate attention to the risks of HRT treatment: stroke, heart attack, blood clots, cardiovascular disease, and cancer. Once these risks were revealed, doctors stopped recommending hormone replacement therapy (HRT) to menopausal women.

They Got The Same Results We Did!(?): In a recent editorial, Nature Medicine provides a warning about scientists who plagiarize previously published science articles. Nature refers to a recently published paper in a journal they magnanimously refer to as "Journal B", which had appeared in Nature six years earlier.

Why would a research scientist so plagiarize? One reason, Nature suggests, is that plagiarism could boost a scientist or student's academic profile in a down economy. The journal provides a how-to:

"use a solid paper as your base; carry out a parallel set of experiments in your favorite model; tweak the data so that the numbers are not identical but remain realistic; and, when you're ready to write it all up, paraphrase the original paper ad libitum. Last, submit your new manuscript to a modest journal in the hopes that the authors of the paper you used as 'inspiration' won't notice your 'tribute' to their work..."

Nature also lists less obvious forms of plagiarism, such as lifting sections of text that adequately express ideas in a language that's not the scientist's primary one, lifting and rephrasing result sections, or scientists' misunderstandings about what is and isn't plagiarism.

When Bad Apples Fall Near The Tree: Talking Points Memo challenges lobbyist Jack Bonner's statement that some "bad employee" sent the forged letters to Congress opposing climate change legislation. The letters were supposedly sent from minority groups, but as it turns out, Bonner's firm was working on behalf of the coal industry. As TPM reports, this was not an isolated incident from a temporary employee but modus operandi for the firm where each employee works first as a temp.

Stem Cell Research Doesn't Always Get Retracted: Really. But lately the Stem Cell Institute at the University of Minnesota in Minneapolis isn't helping prove the point. New Scientist recently raised questions about research from several stem cell labs at the institute. One scientist reprimanded for academic misconduct had so many papers containing errors that three had to be corrected and one retracted.

The journal then decided to look at all the papers coming out of the lab that that former student worked in and found possible duplications in seven papers from another researcher affiliated with the institute. Stem cell scientists made comments to New Scientist, expressing discouragement about the spate of problems at the one institute that happened to be under the spotlight. Given the pressure in the field, these scientists wondered how widespread the problems elsewhere could be.